Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3228128
Max Phase: Preclinical
Molecular Formula: C22H44N4O11
Molecular Weight: 540.61
Molecule Type: Small molecule
Associated Items:
ID: ALA3228128
Max Phase: Preclinical
Molecular Formula: C22H44N4O11
Molecular Weight: 540.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCNC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](NCC)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C22H44N4O11/c1-3-25-6-10-14(29)16(31)17(32)22(34-10)37-20-9(24)5-8(23)19(18(20)33)36-21-15(30)12(26-4-2)13(28)11(7-27)35-21/h8-22,25-33H,3-7,23-24H2,1-2H3/t8-,9+,10-,11-,12+,13-,14-,15-,16+,17-,18-,19+,20-,21-,22-/m1/s1
Standard InChI Key: VQYFNHNGZQSRCW-CHOMWAFYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 540.61 | Molecular Weight (Monoisotopic): 540.3007 | AlogP: -5.99 | #Rotatable Bonds: 10 |
Polar Surface Area: 254.63 | Molecular Species: BASE | HBA: 15 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.05 | CX Basic pKa: 9.54 | CX LogP: -5.48 | CX LogD: -10.98 |
Aromatic Rings: 0 | Heavy Atoms: 37 | QED Weighted: 0.12 | Np Likeness Score: 1.37 |
1. Kumar V, Remers WA.. (1979) Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins., 22 (4): [PMID:107311] [10.1021/jm00190a015] |
Source(1):